The European Commission has approved under EU State aid rules a DKK 240 million (approximately €32 million) Danish scheme to partially compensate media companies for […]
The European Commission has approved, under EU State aid rules, the support granted by Spain to electricity generators for supplying electricity in the Spanish non-peninsular […]
The European Commission has approved a €713 million Dutch aid scheme to support small and medium sized enterprises (SMEs) affected by the coronavirus outbreak. The […]
The Commission has proposed a new, ambitious stand-alone health programme for the 2021-2027 period – the EU4Health Programme. EU4Health will make a significant contribution to […]
The European Commission has today launched its first roundtable meeting with the European financial sector, including consumer and business representatives, to explore how it can […]
The European Commission has welcomed and approvedthe redirection of €30 million from the European Regional Development Fund (ERDF) to help two Italian regions, Emilia Romagna […]
As announced by President von der Leyen, the Commission is proposing a new REACT-EU initiative to increase cohesion support to Member States to make their […]
As announced by European Commission President von der Leyen on 27 May 2020, the centrepiece of the recovery plan will be a new Recovery and […]
UNCTAD and the five UN regional commissions join forces to help developing countries tackle trade and transport challenges from the coronavirus pandemic. A new joint […]
UNCTAD and the WHO have teamed up to respond to the urgent call to boost local production of essential medicines in developing countries. With more […]
• ALEX study is the first global phase III study to show a clinically meaningful benefit in overall survival at five years (62.5% with Alecensa), […]
…..and for people with ROS1-positive, advanced non-small cell lung cancer •Rozlytrek has shown durable responses across multiple tumour types, including cancer that has spread to […]
• Piqray (alpelisib) in combination with fulvestrant will become first and only targeted treatment for advanced breast cancer patients whose tumors harbor a PIK3CA mutation […]
• More than half of patients with BRAF-mutated advanced melanoma taking Tafinlar + Mekinist were alive and free of a relapse at 5-years1 • Study […]
Copyright © 2023 | WordPress Theme by MH Themes
